(0.06%) 5 472.36 points
(0.09%) 39 148 points
(0.36%) 17 781 points
(-0.15%) $80.71
(-3.66%) $2.66
(-0.74%) $2 313.50
(0.25%) $28.94
(3.59%) $1 021.80
(0.28%) $0.936
(0.69%) $10.68
(0.46%) $0.792
(-0.28%) $87.25
Live Chart Being Loaded With Signals
Jounce Therapeutics, Inc., a clinical-stage immunotherapy company, develops therapies for the treatment of cancer. The company develops vopratelimab, a clinical-stage monoclonal antibody, which is in Phase II clinical trial that binds to and activates the Inducible T cell CO-Stimulator, a protein on the surface of T cells found in various solid tumors...
Stats | |
---|---|
今日成交量 | 11.60M |
平均成交量 | 3.47M |
市值 | 98.95M |
EPS | $0.990 ( Q4 | 2023-03-10 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
-1.958 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $0.0820 (4.36%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-05-03 | Concentra Biosciences, Llc | Buy | 10 000 | Common Stock |
2023-05-03 | Tang Kevin C | Buy | 10 000 | Common Stock |
2023-05-03 | Tang Kevin C | Sell | 5 300 087 | Common Stock |
2023-05-03 | Concentra Biosciences, Llc | Buy | 0 | Common Stock |
2023-05-03 | Salter-cid Luisa | Sell | 20 000 | Stock Option (Right to Buy) |
INSIDER POWER |
---|
-97.50 |
Last 98 transactions |
Buy: 1 025 987 | Sell: 8 913 091 |
音量 相关性
Jounce Therapeutics Inc 相关性
10 最正相关 |
---|
10 最负相关 |
---|
你知道吗?
相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1,其中-1表示完全负相关(一个变量增加,另一个变量减少),1表示完全正相关(一个变量增加,另一个变量也增加),0表示没有相关性(变量之间没有关系)。
相关性可用于分析任何两个变量之间的关系,而不仅仅是股票。它通常用于金融、经济学、心理学等领域。
Jounce Therapeutics Inc 相关性 - 货币/商品
Jounce Therapeutics Inc 财务报表
Annual | 2022 |
营收: | $82.00M |
毛利润: | $82.00M (100.00 %) |
EPS: | $-0.990 |
FY | 2022 |
营收: | $82.00M |
毛利润: | $82.00M (100.00 %) |
EPS: | $-0.990 |
FY | 2021 |
营收: | $26 907.00 |
毛利润: | $0.00 (0.00 %) |
EPS: | $-0.00182 |
FY | 2020 |
营收: | $62.34M |
毛利润: | $62 339.00 (0.10 %) |
EPS: | $-1.240 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Jounce Therapeutics Inc
Jounce Therapeutics, Inc., a clinical-stage immunotherapy company, develops therapies for the treatment of cancer. The company develops vopratelimab, a clinical-stage monoclonal antibody, which is in Phase II clinical trial that binds to and activates the Inducible T cell CO-Stimulator, a protein on the surface of T cells found in various solid tumors. It is also developing JTX-8064, an antibody that binds to leukocyte immunoglobulin like receptor B2, which is a cell surface receptor expressed on macrophages; JTX -1484 for myeloid; and JTX-1811, an anti-CCR8 monoclonal antibody designed to selectively deplete intra-tumoral T regulatory cells in the tumor microenvironment. Jounce Therapeutics, Inc. was incorporated in 2012 and is headquartered in Cambridge, Massachusetts.
关于 实时信号
此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。
实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。